Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

Inhibitor Therapeutics, Inc. (INTI)

0.0500
-0.0007
(-1.38%)
At close: April 22 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
3,657.4090
3,657.4090
3,404.9790
657.9260
325.3950
Operating Income
-3,657.4090
-3,657.4090
-3,404.9790
-657.9260
-325.3950
Net Non Operating Interest Income Expense
318.2080
318.2080
378.8440
-23.2340
-14.8370
Other Income Expense
--
--
--
12,842.4990
41.6000
Pretax Income
-3,339.2010
-3,339.2010
-3,026.1350
12,161.3390
-298.6320
Tax Provision
--
--
--
55.1090
--
Net Income Common Stockholders
-3,339.2010
-3,339.2010
-3,026.1350
11,917.1880
-498.6330
Diluted NI Available to Com Stockholders
-3,339.2010
-3,339.2010
-3,026.1350
11,917.1880
-498.6330
Basic EPS
-0.02
--
-0.02
0.03
-0.00
Diluted EPS
-0.02
--
-0.02
0.03
-0.00
Basic Average Shares
172,262.8890
--
171,950.1080
366,183.6970
376,247.7770
Diluted Average Shares
172,262.8890
--
171,950.1080
366,183.6970
376,247.7770
Total Operating Income as Reported
-3,657.4090
-3,657.4090
-3,404.9790
-657.9260
-325.3950
Total Expenses
3,657.4090
3,657.4090
3,404.9790
657.9260
325.3950
Net Income from Continuing & Discontinued Operation
-3,339.2010
-3,339.2010
-3,026.1350
12,106.2300
-298.6320
Normalized Income
-3,339.2010
-3,339.2010
-3,026.1350
-678.0733
-340.2320
Interest Income
318.2080
318.2080
378.8440
--
--
Interest Expense
24.6800
--
--
23.2340
14.8370
Net Interest Income
318.2080
318.2080
378.8440
-23.2340
-14.8370
EBIT
-3,657.4090
-3,657.4090
-3,026.1350
12,184.5730
-283.7950
EBITDA
-3,657.4090
-3,657.4090
-3,026.1350
12,184.5730
-283.7950
Net Income from Continuing Operation Net Minority Interest
-3,339.2010
-3,339.2010
-3,026.1350
12,106.2300
-298.6320
Total Unusual Items Excluding Goodwill
--
--
--
12,842.4990
41.6000
Total Unusual Items
--
--
--
12,842.4990
41.6000
Normalized EBITDA
-3,657.4090
-3,657.4090
-3,026.1350
-657.9260
-325.3950
Tax Rate for Calcs
--
--
--
0
--
Tax Effect of Unusual Items
--
--
--
58.1957
--
12/31/2021 - 9/13/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VXLLF Vaxil Bio Ltd.
0.0129
-7.86%
 
TELO Telomir Pharmaceuticals, Inc.
2.6000
+2.36%
 
RENB Renovaro Inc.
0.3482
-13.32%
 
ATNM Actinium Pharmaceuticals, Inc.
1.3800
+15.00%
 
ATYR aTyr Pharma, Inc.
3.4700
+5.79%
 
SLS SELLAS Life Sciences Group, Inc.
1.2900
0.00%
 
BCTX BriaCell Therapeutics Corp.
5.35
+27.68%
 
VRTX Vertex Pharmaceuticals Incorporated
490.47
+2.71%